Worked better than expectations*
Market cap gains far exceed historical trends: In an equivalent time period prior to the launch of their GLP-1 products, the combined market cap gains for Novo Nordisk and Eli Lilly was significantly lower at $197 billion3.5x less than the gains realized after the introduction of these products
These therapies could target cytokines such as IL-1, TNF-, or IL-6 to reduce inflammation, or employ immune adjuvants to augment the immune response
If youre someone who struggles with bloating, digestion, fatigue, or hydration, joint pain these four are about to become your new best friends
It is also used in the nebulized form as a mucolytic, under the trade name Mucomyst. Should we consider supplementation of antioxidants
Results vary from person to person, and the medication is always used alongside diet, exercise, and medical supervision